ACCELERON PHARMA INC 4 SEC Filings

Filed On	Filing
22 Nov 2021	Form 4: Zakrzewski Joseph S, Director Disposed of 34,499 shares (Tender Offer) · Disposed of 53,907 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Malik Kemal, Director Disposed of 1,622 shares (Tender Offer) · Disposed of 21,178 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Hite Christopher, Director Disposed of 930 shares (Tender Offer) · Disposed of 12,115 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Smith Karen L., Director Disposed of 1,622 shares (Tender Offer) · Disposed of 22,932 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Mccourt Thomas A, Director Disposed of 6,044 shares (Tender Offer) · Disposed of 18,907 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Kearney Terrence C, Director Disposed of 6,749 shares (Tender Offer) · Disposed of 31,072 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Hamill Laura, Director Disposed of 474 shares (Tender Offer) · Disposed of 10,280 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Nader Francois, Director Disposed of 6,749 shares (Tender Offer) · Disposed of 74,483 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Veness Adam M, SVP, General Counsel and Sec. Disposed of 23,423 shares (Tender Offer) · Disposed of 65,990 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Kango Sujay, EVP, Chief Commercial Officer Disposed of 18,509 shares (Tender Offer) · Disposed of 95,730 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Backstrom Jay T., EVP, Research and Development Disposed of 21,233 shares (Tender Offer) · Disposed of 117,859 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Mclaughlin Kevin F, SVP, CFO and Treasurer Disposed of 10,681 shares (Tender Offer) · Disposed of 77,565 Option to Purchase Common Stock (Disposition to Issuer)
22 Nov 2021	Form 4: Dable Habib J, Director Disposed of 98,450 shares (Tender Offer) · Disposed of 614,281 Option to Purchase Common Stock (Disposition to Issuer)
12 Nov 2021	Form 4: Veness Adam M, SVP, General Counsel and Sec. Received 4,500 shares by exercise or conversion ($132K)
27 Sep 2021	Form 4: Kango Sujay, EVP, Chief Commercial Officer Received 5,000 shares by exercise or conversion ($203K) · Sold 5,000 shares ($875K)
24 Sep 2021	Form 4: Mclaughlin Kevin F, SVP, CFO and Treasurer Received 19,630 shares by exercise or conversion ($779K) · Sold 19,630 shares ($3.15M) · Received 5,370 shares by exercise or conversion ($218K) · 1 more
22 Sep 2021	Form 4: Veness Adam M, SVP, General Counsel and Sec. Received 6,650 shares by exercise or conversion ($217K) · Sold 6,650 shares ($998K)
22 Sep 2021	Form 4: Kango Sujay, EVP, Chief Commercial Officer Received 5,000 shares by exercise or conversion ($203K) · Sold 5,000 shares ($750K)
09 Sep 2021	Form 4: Veness Adam M, SVP, General Counsel and Sec. Gave up 587 shares to cover exercise price or tax ($75.9K) · Sold 6 shares ($780) · Sold 1,407 shares ($183K)
02 Jul 2021	Form 4: Dable Habib J, Director Received 57,814 shares by exercise or conversion ($2.03M) · Sold 57,814 shares ($7.33M) · Received 42,186 shares by exercise or conversion ($1.48M) · 1 more

Comments